Diligent Efforts. Novo Nordisk agrees that it will use its Diligent Efforts to develop and commercialize the Insulin Compound Packaged Product and the Device, including without limitation the following:
Appears in 4 contracts
Samples: License Agreement (Aradigm Corp), License Agreement (Aradigm Corp), License Agreement (Aradigm Corp)